Coherus Biosciences Inc (CHRS) is up Friday morning, with the stock gaining 3.23% in pre-market trading to 2.24. CHRS's short-term technical score of 2 indicates that the stock has traded less bullishly over the last month than 98% of stocks on the market. In the Biotechnology industry, which ranks 99 out of 146 industries, the stock ranks higher than 4% of stocks. Coherus Biosciences Inc has fallen 15.23% over the past month, closing at $2.76 on February 16. During this period of time, the stock fell as low as $2.18 and as high as $2.85. CHRS has an average analyst recommendation of Strong Buy. The company has an average price target of $9.00.
CHRS has an Overall Score of 34. Find out what this means to you and get the rest of the rankings on CHRS!